Nepal Health Research Council
17
2
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.9%
1 terminated/withdrawn out of 17 trials
87.5%
+1.0% vs industry average
29%
5 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Evaluating Emetine for Viral Outbreaks (EVOLVE)
Role: collaborator
Development and Testing of a Mobile Health Application for Management of Gestational Diabetes
Role: collaborator
Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms
Role: collaborator
Comparison of Stent-Related Symptoms: Regular Double J Stent vs. Comfi J Stent
Role: collaborator
Comparative Analytical Study of Intravenous Bolus Dose of Mephentermine and Phenylephrine for Hemodynamic Stability During Elective Cesarean Section Under Spinal Anesthesia at KIST Medical College and Teaching Hospital
Role: collaborator
A Clinical Guideline-based Management of Type-2 Diabetes by Ayurvedic Practitioners in Nepal
Role: lead
A Study on Pigmentation Disorders in Children
Role: lead
Enteral Resuscitation Nepal
Role: lead
Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal
Role: lead
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
Role: collaborator
Intralesional Triamcinolone Acetonide and Its Combination With 5-fluorouracil in Keloids and Hypertrophic Scars
Role: collaborator
Add-on Study on WHO Solidarity Trial Plus for COVID-19 in Nepal
Role: lead
Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis
Role: collaborator
A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts
Role: collaborator
Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19
Role: lead
Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal
Role: lead
Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study
Role: lead
All 17 trials loaded